focus -WSS

focus

author：explore 2025-10-01 21:41:07 - browse：7996

Vials and packaging for Leqembi, a new Alzheimer's medication approved in the U.S., but not yet in Europe. Illustration: Alex Hogan/STAT; Photo: Eisai via AP

LONDON — Starting Sunday, Alzheimer’s specialists will gather for a major conference in Amsterdam, convening at a time when the field, depending on which expert you ask, has some rare momentum behind it, with new therapies starting to show benefits for patients.

But despite the hard-won victories, the arrival of the new therapies presents a new set of challenges in Europe as countries plan for their possible rollouts, scientists and doctors told STAT.

Health systems will have to adapt to diagnose people earlier and monitor them for side effects associated with the treatments. If their medicines win European approval, companies will have to strike reimbursement deals in all member states, a process that often leaves some countries waiting years for new drugs to become available. The hurdles mean the therapies will likely be offered only at certain centers initially, constraining how many patients have access to them, doctors from across Europe said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Mirador, a new biotech startup, launches with $400 million

hotspot

focus

WSS

This gene therapy has record $4.25 million price. It's saved children.

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

Erich Jarvis studies song birds to learn about human stuttering

A rare thyroid diagnosis led to unexpected, all

'Make People Better': The CRISPR babies story you probably don't know

Steward Health Care expansion into Malta flopped

knowledge

focus

leisure time

As demand for Covid shots wanes, Moderna seeks its next success

What American doctors can learn from their Israeli counterparts

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

NIH nominee Bertagnolli will get October confirmation hearing

Wildfire smoke exposes gaps in outdoor worker protections

What drug price negotiations mean for Medicare Part D

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Asbestos ban is immediate, but health effects will linger for decades

Psychedelics group wrestles with new pharma identity

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

leisure time

CRISPR technology availability, affordability needs to be expanded

A new House health package & hospitals’ new site

Erich Jarvis studies song birds to learn about human stuttering

Steward Health Care expansion into Malta flopped

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

Cancer, immunology, HIV research ensnared in fetal tissue politics

hotspot

hotspot

focus

explore